Public limited company · Bruxelles · incorporated on 02/05/1974 · 18,4 ETP
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8,5 M € | -2.7% | 8,7 M € | -0.6% | 8,8 M € | +7.9% | 8,1 M € | — | — | — | — | — | — | 7,4 M € | +4.2% | 7,1 M € | -18.8% | 8,7 M € | -14.7% | 10,2 M € | +7.3% | 9,5 M € | +4.5% | 9,1 M € | +8.2% | 8,4 M € | +17.1% | 7,2 M € | +0.8% | 7,1 M € | ||||||||
| Gross margin | — | — | — | — | 3,5 M € | +2.4% | 3,4 M € | +6.0% | 3,2 M € | +7.7% | 3,0 M € | -4.0% | 3,1 M € | +2.0% | 3,0 M € | — | — | — | — | — | — | — | — | — | ||||||||||||||
| EBITDA | 2,0 M € | +18.3% | 1,7 M € | +3.9% | 1,6 M € | -0.6% | 1,6 M € | +1.5% | 1,6 M € | +15.1% | 1,4 M € | +4.6% | 1,3 M € | +19.7% | 1,1 M € | -5.9% | 1,2 M € | -4.9% | 1,3 M € | -10.1% | 1,4 M € | +0.1% | 1,4 M € | +15.0% | 1,2 M € | +13.1% | 1,1 M € | +2.9% | 1,0 M € | +6.8% | 978,6 k € | +26.7% | 772,2 k € | +1.4% | 761,3 k € | +0.3% | 758,7 k € | |
| Operating profit | 1,9 M € | +18.9% | 1,6 M € | +3.9% | 1,6 M € | -0.8% | 1,6 M € | +2.6% | 1,5 M € | +14.2% | 1,3 M € | +5.4% | 1,3 M € | +20.4% | 1,1 M € | -6.8% | 1,1 M € | -4.7% | 1,2 M € | -10.6% | 1,3 M € | +0.1% | 1,3 M € | +17.1% | 1,1 M € | +17.2% | 974,3 k € | +12.6% | 865,5 k € | +7.7% | 803,7 k € | +40.8% | 571,0 k € | -4.1% | 595,4 k € | -8.8% | 652,9 k € | |
| Profit/loss | 1,9 M € | +67.7% | 1,2 M € | -23.0% | 1,5 M € | +0.1% | 1,5 M € | -0.8% | 1,5 M € | -7.9% | 1,6 M € | +5.9% | 1,6 M € | +8.7% | 1,4 M € | +8.4% | 1,3 M € | -0.9% | 1,3 M € | -15.1% | 1,6 M € | -1.6% | 1,6 M € | +4.7% | 1,5 M € | +20.4% | 1,3 M € | +15.7% | 1,1 M € | -0.3% | 1,1 M € | +9.0% | 1,0 M € | -11.9% | 1,1 M € | +21.9% | 937,3 k € | |
| Equity | 11,3 M € | +0.1% | 11,3 M € | +0.1% | 11,3 M € | +3.7% | 10,9 M € | +4.9% | 10,4 M € | +5.3% | 9,9 M € | +8.2% | 9,1 M € | +8.4% | 8,4 M € | +9.2% | 7,7 M € | +8.0% | 7,1 M € | +5.7% | 6,8 M € | +9.2% | 6,2 M € | -18.5% | 7,6 M € | -31.4% | 11,1 M € | +3.4% | 10,7 M € | +3.8% | 10,3 M € | +5.0% | 9,8 M € | +5.4% | 9,3 M € | -10.2% | 10,4 M € | |
| Total assets | 14,3 M € | +5.4% | 13,5 M € | -1.7% | 13,8 M € | +3.7% | 13,3 M € | +7.0% | 12,4 M € | +5.7% | 11,7 M € | +5.6% | 11,1 M € | +9.2% | 10,2 M € | +7.6% | 9,5 M € | +5.7% | 9,0 M € | +1.2% | 8,9 M € | +8.6% | 8,2 M € | -14.2% | 9,5 M € | -27.7% | 13,2 M € | +5.4% | 12,5 M € | +6.6% | 11,7 M € | +5.6% | 11,1 M € | -9.2% | 12,2 M € | -1.5% | 12,4 M € | |
| Cash | 1,4 M € | +32.2% | 1,1 M € | +18.9% | 917,6 k € | -35.1% | 1,4 M € | +19.1% | 1,2 M € | +10.1% | 1,1 M € | +56.0% | 691,6 k € | +7.5% | 643,4 k € | -7.3% | 693,8 k € | -23.2% | 903,5 k € | -28.5% | 1,3 M € | -15.8% | 1,5 M € | -5.5% | 1,6 M € | +10.1% | 1,4 M € | +65.4% | 871,9 k € | -9.2% | 960,6 k € | +6.1% | 905,0 k € | +118.9% | 413,3 k € | -46.4% | 771,5 k € | |
| Debts | 2,9 M € | +34.3% | 2,1 M € | -8.4% | 2,3 M € | +3.4% | 2,3 M € | +18.2% | 1,9 M € | +8.5% | 1,8 M € | -5.2% | 1,9 M € | +11.8% | 1,7 M € | +3.3% | 1,6 M € | -5.3% | 1,7 M € | -14.4% | 2,0 M € | +6.5% | 1,9 M € | +6.8% | 1,7 M € | +1.6% | 1,7 M € | +5.0% | 1,6 M € | +24.2% | 1,3 M € | +6.1% | 1,2 M € | -56.5% | 2,8 M € | +44.8% | 2,0 M € | |
| Staff | 18,4 | 21,3 | 21,3 | 20 | 18,9 | 21,2 | 20,2 | 19 | 21,5 | 20,8 | 16,6 | 15,1 | 17,7 | 18,7 | 17,6 | 18,1 | 18 | 17,4 | 18,2 | |||||||||||||||||||
Public limited company profitable and well capitalised. Cash position rising (+32.2%).
Solid counterparty for a standard engagement.
VYGON is a Public limited company incorporated in 1974. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Bruxelles. It employs on average 18,4 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette